Disruptive Therapy: David Liu and Gene-editing

December 20, 2017
The Inner Ear

On December 20, 2017, following Professor David Liu and colleague's eruptive publication in Nature, the Massachusetts Eye and Ear and Broad Institute released the below joint press release.

“This is an exciting study that demonstrates the feasibility of a DNA-free, virus-free genome editing strategy for a type of autosomal dominant hearing loss characterized by progressive hair cell loss,” said Tina Stankovic, an associate professor at Mass. Eye and Ear, who was unaffiliated with the work. "Augmenting the toolbox to treat genetic deafness is of major significance."

 

CRISPR therapy preserves hearing in progressive deafness model

Read more

 

Photo Credit: Credit Joseph Burns, Ph.D., National Institute on Deafness and Other Communication Disorders, National Institutes of Health